Ara
Toplam kayıt 15, listelenen: 11-15
Letter by Guner et al Regarding Article, Giant Coronary Aneurysms in a Patient With Immunoglobulin G4-Related Disease
(Lippincott Williams & Wilkins, 2020)
To the Editor: We have recently read with great interest the article by Zheng et al1 entitled “Giant Coronary Aneurysms in a Patient With Immunoglobulin G4-Related Disease.” We appreciate the authors for their reports ...
Twenty-seven-year durability of St. Jude Medical Biocor bovine bioprosthesis in mitral position
(Turkish Soc Cardiology, 2020)
A 67-year-old female patient had undergone mitral valve replacement 27 years earlier with a 29-mm St. Jude Medical Biocor bovine bioprosthesis valve (St. Jude Medical Inc., St. Paul, MN, USA) due to mitral stenosis.
PDB100 - Cost-Effectiveness of Exenatide Twice Daily (Bid) Added To Basal Insulin Compared To A Bolus Insulin Add-On In Turkey
(Elsevier Science Inc, 2014)
Objectives
Type 2 diabetes (T2D) patients on basal insulin with uncontrolled HbA1c levels often receive an add-on with bolus insulin to lower HbA1c levels. The aim of this analysis is to estimate long-term cost-effectiveness ...
PDB136 - Importance of Hypoglycemia Barrier on The Treatment of Diabetes Mellitus (Dm) – Survey With Turkish Physicians
(Elsevier Science Inc, 2015)
Objectives
The purpose of this study was to assess the magnitude of hypoglycemia barrier in terms of physician’s treatment choices and algorithm and the impact of hypoglycemia in adherence and persistence to insulin treatment.
Should the Therapeutic Apheresis Method Be Added to Treatment in the COVID-19 Outbreak?
(Karger, 2021)
Dear Editor, The coronavirus outbreak, which started in Wuhan, a city in China, in December 2019, soon spread across the world and was declared a pandemic by the World Health Organization. The disease was identified as ...